McGuire v. Dendreon Corp.

688 F. Supp. 2d 1239, 2009 U.S. Dist. LEXIS 124834, 2009 WL 5788761
CourtDistrict Court, W.D. Washington
DecidedMay 21, 2009
DocketC07-800MJP
StatusPublished
Cited by4 cases

This text of 688 F. Supp. 2d 1239 (McGuire v. Dendreon Corp.) is published on Counsel Stack Legal Research, covering District Court, W.D. Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McGuire v. Dendreon Corp., 688 F. Supp. 2d 1239, 2009 U.S. Dist. LEXIS 124834, 2009 WL 5788761 (W.D. Wash. 2009).

Opinion

ORDER ON MOTION TO DISMISS THE SECOND AMENDED COMPLAINT

MARSHA J. PECHMAN, District Judge.

The above-entitled Court, having received and reviewed

1. Motion to Dismiss the Second Amended Class Action Complaint (Dkt. No. 105)

2. Plaintiffs’ Opposition to Defendants’ Motion to Dismiss the Second Amended Class Action Complaint (Dkt. No. 107)

3. Defendants’ Reply Brief in Support of Their Motion to Dismiss the Second Amended Class Action Complaint (Dkt. No. Ill)

and all attached declarations and exhibits, makes the following ruling:

IT IS ORDERED that the motion is PARTIALLY GRANTED and PARTIALLY DENIED; the 10(b)/10b-5 claims against Defendant Urdal are DISMISSED; the remainder of the motion is DENIED.

IT IS FURTHER ORDERED that Plaintiffs will be granted leave to amend their complaint; the amended complaint must be filed no later than June 8, 2009.

Background

On December 5, 2008, 2008 WL 5130042 this Court ruled on Defendants’ previous Motion to Dismiss, dismissing the 10(b)/ 10b-5 claims against Defendant Gold but refusing to dismiss similar claims against Defendant Urdal. Dkt. No. 100. The request to dismiss the claims against Defendant Urdal was denied on the basis of a statement of opinion by Urdal to a group of analysts wherein he represented that *1241 the corporation had “hosted a good inspection” at them manufacturing plant as part of the approval process by the Food and Drug Administration (“FDA”) of Dendreon’s Biologies License Application (“BLA”) for a proposed prostrate cancer treatment drug called Provenge. What Urdal did not reveal to the analysts during that conversation was that, following the inspection, the FDA had issued an “Inspectional Observations Report” known as a Form 483, a document which is not issued unless there are “significant objectionable conditions” at a facility. Id., pp. 2-3.

Additionally, the December 2008 order dismissed an insider trading claim against Defendant Gold because the named plaintiff did not purchase his Dendreon stock sufficiently near in time to Gold’s sale of stock to satisfy the elements of the cause of action. Plaintiffs were given permission to amend to name a more suitable purchaser as the plaintiff representative for this claim. Id., pp. 15-16.

Following the issuance of the order, Plaintiffs filed a Second Amended Complaint (“SAC”) on January 5, 2009. Dkt. No. 101.

Discussion

Defendant Urdal-10(b)/10b-5 Claims

The Court’s ruling in Plaintiffs’ favor regarding the adequacy of the 10(b)/ 10b-5 pleadings against Urdal rested on a Ninth Circuit opinion called In re Apple Computer Sec. Litig., 886 F.2d 1109, 1113 (9th Cir.1989), which held that “projections and general expressions of optimism may be actionable under the federal securities laws.” The Ninth Circuit in Apple Computer formulated the following test for determining whether these kinds of statements could form the basis of a securities cause of action:

A projection or statement of belief contains at least three implicit factual assertions: (1) that the statement is genuinely believed, (2) that there is a reasonable basis for that belief, and (3) that the speaker is not aware of any undisclosed facts tending to seriously undermine the accuracy of the statement. A projection or statement of belief may be actionable to the extent that one of the implied factual assertions is inaccurate.

Id. at 1113 (emphasis supplied; citation omitted).

Defendants in their previous motion to dismiss argued against the application of Apple Computer, claiming that its holding was confined to statements regarding future event or projections. They cited Virginia Bankshares, Inc. v. Sandberg, 501 U.S. 1083, 111 S.Ct. 2749, 115 L.Ed.2d 929 (1991) as the “more appropriate” standard and pointed to In re McKesson HBOC, Inc. Sec. Litig., 126 F.Supp.2d 1248 (N.D.Cal.2000) as an example of this circuit’s application of Virginia Bankshares. Wfiiat Defendants were arguing for was a standard for assessing the actionability of an opinion statement which required that the statement not only be objectively false, but also subjectively false; i.e., that the statement was not true and the speaker did not believe it to be true. McKesson does in fact say that, but the opinion represents a further extension of the Virginia Bankshares holding (the district court said “Virginia Bankshares is not squarely on point....;” Id. at 1264) and this Court concluded that the opinion could not be read to say that “an opinion statement is only actionable if subjectively and objectively false.” Dkt. No. 100 at p. 8.

Furthermore, Defendants in their prior pleading asserted that “the distinction between the [Apple and Virginia Bankshares/McKesson ] standards is without a difference, and the Court need not decide which applies.” Reply on Mtn. to Dismiss FAC, p. 6. The Court did not find that contention persuasive — the standards *1242 are clearly disparate — and ultimately concluded that Apple Computer controlled— because (1) it spoke so clearly to “statement[s] of belief,” an accurate characterization of Urdal’s “good inspection” comment; and (2) there was no indication in the case history that Apple Computer had ever been overruled.

The centerpiece of Defendants’ latest motion to dismiss is a January 2009 opinion, Rubke v. Capitol Bancorp, 551 F.3d 1156 (9th Cir.2009) (“Rubke ”). The case concerns a share-exchange offering wherein the offering document was accompanied by two “fairness opinions” from financial analyst groups which concluded that the offering was “fair from a financial point of view.” Id. at 1159. It later turned out that an earlier, virtually identical offering had been transacted under better terms than the Rubke plaintiffs were offered. In dismissing the first amended complaint, the Ninth Circuit held that:

Because these fairness determinations are alleged to be misleading opinions, not statements of fact, they can give rise to a claim ... only if the complaint alleges with particularity that the statements were both objectively and subjectively false or misleading. See Va. Bankshares, Inc. v. Sandberg, 501 U.S. 1083, 1095-96, 111 S.Ct. 2749, 115 L.Ed.2d 929 (1991); In re McKesson HBOC, Inc. Sec. Litig., 126 F.Supp.2d 1248, 1265 (N.D.Cal.2000).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Fialkov v. Microsoft Corp.
72 F. Supp. 3d 1220 (W.D. Washington, 2014)
Buttonwood Tree Value Partners, LP v. Sweeney
910 F. Supp. 2d 1199 (C.D. California, 2012)
Public Pension Fund Group v. KV PHARMACEUTICAL CO.
679 F.3d 972 (Eighth Circuit, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
688 F. Supp. 2d 1239, 2009 U.S. Dist. LEXIS 124834, 2009 WL 5788761, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mcguire-v-dendreon-corp-wawd-2009.